The University of Chicago Header Logo

Connection

Mark Kozloff to Risk Assessment

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Risk Assessment.
Mark Kozloff
Connection Strength
0.024
Risk Assessment
  1. A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies. Cancer. 2019 05 15; 125(10):1629-1636.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.